Introduction
Carbapenem resistance in Pseudomonas aeruginosa is mainly related to acquired carbapenem-hydrolysing b-lactamases or OprD2 porin deficiency. 1, 2 Carbapenemases are able to hydrolyse most if not all b-lactams, including carbapenems. 3 The carbapenemases currently found in P. aeruginosa belong to Ambler classes A (GES and KPC), B (IMP, VIM, NDM, SPM, AIM and GIM) and rarely D (OXA-198). 1, 3, 4 Currently, the class A carbapenemases most frequently found in P. aeruginosa are the KPC enzymes. 1 KPC carbapenemases were initially described in a Klebsiella pneumoniae isolate in 2001 in North Carolina, 5 and have since rapidly emerged and disseminated throughout the world, in particular in enterobacterial species.
1 KPC-producing P. aeruginosa isolates, initially reported in 2006 from Colombia 6 and subsequently in Puerto Rico, in Trinidad and Tobago, in the USA 7 and in China, 8 are increasingly being isolated in the Americas and in the Caribbean region. 1, 9 The rapid spread of bla KPC genes has been linked to their location on a Tn4401, a Tn3-based transposon capable of high-frequency transposition, 10 which itself is present on a wide variety of plasmids varying in size, nature and structure between enterobacterial isolates. 1, 11 Another explanation is likely to be linked to its presence in epidemic clones such as K. pneumoniae ST258.
1 Several KPC-producing P. aeruginosa isolates from different Colombian hospitals have revealed the spread of different clones, harbouring either chromosome-or plasmid-encoded bla KPC-2 genes. The plasmids were different in size and contained bla KPC-2 genes associated with two different genetic structures. Most of the isolates contained the isoform Tn4401b located on an 40 kb plasmid, and one isolate contained a novel genetic environment of a bla KPC-2 gene located on an 10 kb plasmid. 9 The aim of this work was to characterize the complete sequence of and to provide further insight into these two different plasmids isolated from KPC-producing P. aeruginosa isolates from Colombia.
Materials and methods
Bacterial isolates and antimicrobial susceptibility testing P. aeruginosa COL-1 was chosen as a representative KPC-2-producing P. aeruginosa isolate responsible for an outbreak in Medellin and harbouring KPC-2 embedded in a Tn4401b structure, while P. aeruginosa PA-2 was chosen as a KPC-2-producing P. aeruginosa isolate possessing a KPC-2 gene in a different genetic environment compared with Tn4401b. 9 Escherichia coli TOP10 (Invitrogen, Eragny, France) was used for electroporation experiments as previously described. 9 Transformants were selected on Trypticase soy agar plates supplemented with 100 mg/L amoxicillin. Routine antibiograms were determined by the disc diffusion method on Mueller-Hinton agar (Bio-Rad, Marnes-La-Coquette, France), and the susceptibility breakpoints were as recommended by the CLSI. 12 
Genetic and molecular analyses
Whole DNAs were extracted using a QiaAmp DNA Mini Kit (Qiagen, Les Ulis, France). Plasmid DNA was extracted using the Qiagen Maxi Kit (Qiagen) and by the Kieser extraction method. Naas et al.
Sanger sequencing was used to sequence small plasmids, using an Applied Biosystems sequencer (ABI 3100), and analysed with software available over the Internet at the National Center for Biotechnology Information web site (http://www.ncbi.nlm.nih.gov). Plasmid assembly was performed using the program DNA Strider 3.0 (CEA, Saclay, France).
High-density pyrosequencing was used for larger plasmids, using an Illumina Genome Analyzer IIx system (Illumina Inc., San Diego, CA, USA). The complete sequencing work flow was performed by the DNAVision company (Gosselies, Belgium). Plasmid assembly was performed using CLC Genomics Workbench 5 software (CLC Genomics, Copenhagen, Denmark).
Nucleotide accession numbers
The annotated nucleotide sequences of plasmids pCOL-1 and pPA-2 were submitted to the GenBank database and are accessible under the accession numbers KC609323 and KC609322, respectively.
Results and discussion
The plasmidic location of the bla KPC-2 gene in P. aeruginosa COL-1 isolated from a hospital in Medellin, Colombia, was initially suggested by Cuzon et al. 9 Subsequently, plasmids of similar size to pCOL-1 were identified in several KPC-producing P. aeruginosa isolates from different Colombian cities. 9 A second plasmid, pPA-2, different in size from pCOL-1, was recovered from a clinical isolate of P. aeruginosa isolated in Bogota, Colombia. 9 The whole-cell DNAs of these two P. aeruginosa isolates were electroporated into E. coli TOP10. Transformants of E. coli TOP10 could be obtained with both natural plasmids.
The two transformants were resistant to amoxicillin, ticarcillin, piperacillin, piperacillin/tazobactam, cefotaxime, ceftazidime, aztreonam and cefepime, and remained susceptible or with an intermediate range of susceptibility to carbapenems (imipenem 
General features of plasmid pCOL-1
High-throughput sequencing revealed that the plasmid pCOL-1 was 31529 bp in size with an average GC content of 60% and contained 31 open reading frames (ORFs). The replication module present on this plasmid belonged to the IncP-6 group. This plasmid exhibited an array of genes involved in replication, mobilization and partition, but none involved in conjugation (Table 1 and Figure 1 ). This is in accordance with previous observations of a plasmid unable to transfer the carbapenem resistance marker via conjugation. 9 The plasmid architecture observed in pCOL-1 was similar to that of other IncP-6 plasmids previously sequenced (Figure 1 ).
The plasmid backbone exhibited high gene synteny with plasmid pRSB105, which encodes several resistance determinants including the bla OXA-10 gene and macrolide resistance genes.
14 This IncP-6 replicon module has also recently been identified in association with the extended-spectrum b-lactamase (ESBL) bla BES-1 gene in a Serratia marcescens clinical isolate from Brazil. 15 In comparison, the plasmid pRIO-5 carrying the ESBL bla BES-1 gene exhibited only four genes of the IncP-6 backbone involved in partition and replication (parA, parB, parC and repA) (Figure 1 ).
Plasmid pCOL-1 harboured the isoform Tn4401b
Only a single antibiotic resistance gene was identified on pCOL-1, the bla KPC-2 gene, which is compatible with susceptibility testing results. The bla KPC-2 gene was a part of the Tn4401 isoform b transposon, which confirms the results obtained by Cuzon 9 who used a PCR mapping approach to identify the Tn4401b isoform. This isoform exhibited the complete form, i.e. without any deletion as observed in Tn4401a (2100 bp) and Tn4401c (2200 bp). 7 The sequence upstream of the bla KPC-2 gene was identical to previously sequenced Tn4401b, 7 and ISKpn7, which has recently been found to be involved in the expression of the bla KPC-2 gene. 16 Both promoters P1 and P2, known to be involved in bla KPC-2 gene expression in E. coli, were identified. The transposon Tn4401b was inserted into the IncP-6 backbone within orf6, which codes for a protein of unknown function (Figure 1 ). orf6 is close to the oriV and replicase region. In pRIO-5, this part of the IncP-6 backbone was missing, suggesting that the DNA sequences located next to the replicase gene might serve as hotspots of DNA integration, as observed for other plasmid types. 17 General features of plasmid pPA-2 Plasmid pPA-2 was 7995 bp in size with an average GC content of 56%, and contained seven ORFs. This plasmid exhibited a replicase gene, but was lacking the genes involved in mobilization, partition and conjugation ( Figure 2 and Table 2 ). These results are in accordance with the fact that this plasmid could not be transferred through conjugation. 9 The klcA gene, coding for an antirestriction protein, and the korC gene, coding for a transcriptional regulator, were also identified on this plasmid. The korC gene is likely to be functional since the region upstream of the gene and the gene itself were intact.
According to the replicase sequence, this plasmid belonged to the IncU incompatibility group. Resistance plasmids assigned to the IncU incompatibility group have been isolated from a number of Aeromonas species and E. coli strains from seawater fish hatcheries and diseased fish, as well as from clinical environments. Members of the IncU plasmid group are particularly implicated in the dissemination of antibiotic resistance in Aeromonas strains associated with aquatic environments.
18
Plasmid pPA-2 harboured a novel genetic environment containing the bla KPC-2 gene
The bla KPC-2 gene in this plasmid was not associated with an entire transposon Tn4401. Only 2072 bp matched to Tn4401, including the bla KPC-2 gene and part of ISKpn6 that was fused to another gene traN (Figure 3a) . This ISKpn6-like element shared a 1039 bp fragment with ISKpn6. Target site duplication and the inverted repeat left described in Tn4401 are present, but the ORF encoding the putative transposase (439 amino acids in ISKpn6) is truncated in its N-terminus by a 117 bp fragment encoding the C-terminal region of a protein sharing 100% amino acid identity with the TraN protein from plasmid pFBAOT6 described in Aeromonas punctata (GenBank accession no. NC_006143). Upstream of the bla KPC-2 gene, only a 73 bp segment is identical to Tn4401, which is interrupted by a Tn3 transposon, itself interrupted by an IS26 element inserted within the bla TEM-1 gene. Similar structures have recently been described in K. pneumoniae isolates from China and Argentina. 19 Tn3 insertion occurred immediately upstream of the 235 box of the P1 promoter responsible for the expression of the bla KPC gene. In this situation, the bla KPC gene is likely to still be expressed from its native P1 promoter, 16 as well as by the outward-directed promoter of Tn3. This pOUT promoter has previously been shown to be involved in the expression of a gentamicin resistance gene in Enterobacteriaceae (Figure 3b ). 20 
Conclusions
Unlike the widespread occurrence of KPC-producing Enterobacteriaceae, P. aeruginosa isolates expressing KPC carbapenemase seem to be geographically limited. The presence of bla KPC in 16, 20 With Tn3 being inserted immediately upstream of the 235 box of the bla KPC gene, it is likely that the bla KPC-2 gene is still expressed from its native P1 promoter, as well as from the outward promoter of Tn3, as previously described for gentamicin resistance gene expression. 20 bla KPC-2 -harbouring plasmids from P. aeruginosa P. aeruginosa isolates is worrying in a species that is known to be prone to becoming carbapenem resistant by multiple mechanisms. The association of Tn4401, a high-frequency transposable element lacking target site specificity, together with successful plasmid backgrounds is an additional source of concern since bla KPC genes possess all the required features for efficient dissemination in Enterobacteriaceae, as well as in nonenterobacterial species such as P. aeruginosa or Acinetobacter baumannii.
Two different plasmids carrying the same carbapenemase bla KPC-2 gene in P. aeruginosa have been described here. Therefore, in Colombia, at least two different plasmid backbones associated with bla KPC-2 are circulating: (i) the IncP-6-type plasmid, which possesses the ability to replicate both in Pseudomonas species and in Enterobacteriaceae and contains a full Tn4401 element; 14 and (ii) the IncU-type plasmid, which is frequently associated with antibiotic resistance in Aeromonas species and contains a truncated form of the Tn4401 transposon. 18 In Enterobacteriaceae the bla KPC gene was associated with IncFII, as well as with IncL/M-and IncN-type, plasmids. 11, 21 In a Pseudomonas putida isolate from Brazil, the bla KPC-2 gene was associated with a Tn4401c isoform located on a 65 kb IncFI plasmid, a plasmid backbone different from those described in this work and frequently encountered in Enterobacteriaceae. 22 These findings show a high diversity of plasmids carrying the bla KPC-2 gene, which is, in most cases, related to the presence of Tn4401, a key genetic determinant for its interplasmid mobility.
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